CLA-2-30:OT:RR:NC:N1:138
Ms. Tanya Hurley
BluePoint Laboratories
8 Eastgate Avenue, Eastgate Business Park
Little Island, Cork, Ireland
RE: The tariff classification of Cyanocobalamin for Injection in dosage form, from India
Dear Hurley:
In your letter dated September 22, 2017, you requested a tariff classification ruling.
Cyanocobalamin Injection is a synthetic form of Vitamin B12 that is indicated for the treatment of Vitamin B12 deficiencies due to malabsorption which may be associated with the following conditions: Addisonian (pernicious) anemia, gastrointestinal pathology, dysfunction, or surgery, including gluten sprue-like enteropathy, small bowel bacterial overgrowth, total or partial gastrectomy, fish tapeworm infestation, malignancy of the pancreas or bowel and folic acid deficiency. Cyanocobalamin Injection will be imported in 1,000 mcg/mL multiple use vials.
The applicable subheading for Cyanocobalamin Injection in dosage form will be 3004.50.5020, Harmonized Tariff Schedule of the United States (HTSUS), which provides for "Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other medicaments containing vitamins or other products of heading 2936: Other: Other: Single vitamins: Other." The rate of duty will be free.
Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at https://hts.usitc.gov/current.
This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov.
This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177).
A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected].
Sincerely,
Steven A. Mack
Director
National Commodity Specialist Division